Humanrace Suncare SPF 30 Sunscreen Recalled for Subpotent Protection
HUMANRACE is recalling Humanrace Suncare Ozone Face Protection Daily Moisturizer SPF 30 because the product does not contain the declared SPF level. Affected consumers should discontinue use immediately.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a risk-of-harm product where consumers may receive inadequate UV protection while believing they have SPF 30 protection. Although classified as FDA Class II, the source reports no illnesses, injuries, or hospitalizations, so the score does not exceed 3 per the rubric.
Plain-English summary
HUMANRACE is recalling Humanrace Suncare Ozone Face Protection Daily Moisturizer, Broad Spectrum Sunscreen SPF 30 (53mL/1.8 fl oz. bottles, NDC 82779-01) because the product does not contain the sun protection factor (SPF) level declared on the label. This is a subpotent drug recall.
The recalled product was distributed nationwide in the United States, Spain, Italy, United Kingdom, and France. Affected lot numbers are 1732A, 1732B, 1742A, 1742B, 1742C, and 1742D, with expiration date 06/2024. Approximately 5046 units are affected.
Consumers who have purchased this product should discontinue use immediately. The product does not provide the sun protection factor claimed on the label, which may result in inadequate protection from ultraviolet (UV) radiation. Consumers with questions should contact HUMANRACE at 2022 Beverly Hills, CA 90210, USA, or the FDA.
The recalled product
- Product
- Humanrace Suncare, Ozone Face Protection Daily Moisturizer, Broad Spectrum Sunscreen SPF 30, packaged as a 53mL (1.8 fl oz.) bottle, 100% mineral, Active Ingredient: Zinc oxide 15%, Snow Mushroom, Dist. By: @Humanrace 2022 Beverly Hills, CA 90210, USA, NDC 82779-01
- Manufacturer
- HUMANRACE
- Category
- Drug — Topical Sunscreen
- Hazard
- mis-labeling
- subpotent-spf
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Lot #: 1732A
- 1732B
- 1742A
- 1742B
- 1742C
- 1742D
- Exp. 06/2024.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27